angiotensin ii has been researched along with Pulmonary Disease, Chronic Obstructive in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, CCMY; Gan, PXL; Heng, CKM; Liao, W; Mei, D; Tran, QTN; Wong, WSF | 1 |
| Cui, Y; Rong, Q; Wang, C; Wang, F; Zhang, Y; Zhu, Y | 1 |
| Heng, CKM; Liao, W; Mei, D; Tan, WSD; Wong, WSF | 1 |
| Fortin, C; Lacasse, Y; Lacourciere, Y; Maltais, F; Marquis, K; Poirier, P | 1 |
| Argyropoulou, E; Kaparianos, A | 1 |
| Mancini, GB | 1 |
| Li, G; Xu, J | 1 |
2 review(s) available for angiotensin ii and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Humans; Hypertension, Pulmonary; Peptidyl-Dipeptidase A; Pulmonary Disease, Chronic Obstructive; Renin-Angiotensin System; Severe Acute Respiratory Syndrome | 2011 |
The 'double dip' hypothesis: simultaneous prevention of cardiovascular and pulmonary morbidity and mortality using angiotensin II type 1 receptor blockers.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Humans; Pulmonary Disease, Chronic Obstructive; Receptor, Angiotensin, Type 1; Risk Factors | 2005 |
2 trial(s) available for angiotensin ii and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Effects of aerobic exercise training and irbesartan on blood pressure and heart rate variability in patients with chronic obstructive pulmonary disease.
Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography, Ambulatory; Exercise; Exercise Test; Exercise Therapy; Female; Follow-Up Studies; Forced Expiratory Volume; Heart Rate; Humans; Irbesartan; Male; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Tetrazoles; Treatment Outcome | 2008 |
[Observation on short-term effects of Angelica injection on chronic obstructive pulmonary disease patients with pulmonary hypertension].
Topics: Aged; Angiotensin II; Drugs, Chinese Herbal; Endothelin-1; Female; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Vasodilator Agents | 2000 |
3 other study(ies) available for angiotensin ii and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Angiotensin II type-2 receptor activation in alveolar macrophages mediates protection against cigarette smoke-induced chronic obstructive pulmonary disease.
Topics: Angiotensin II; Animals; Cigarette Smoking; Imidazoles; Inflammation; Macrophages, Alveolar; Mice; Mitogen-Activated Protein Kinase Phosphatases; NF-kappa B; Nicotiana; Pulmonary Disease, Chronic Obstructive; Receptor, Angiotensin, Type 2; Sirtuin 1; Sulfonamides; Thiophenes | 2022 |
Continuous hemodiafiltration as a rescue therapy for patients with cardiopulmonary failure caused by enterovirus-71: a retrospective observational study in a PICU.
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Catecholamines; Child, Preschool; China; Continuous Renal Replacement Therapy; Enterovirus A, Human; Female; Follow-Up Studies; Hand, Foot and Mouth Disease; Hemodiafiltration; Humans; Infant; Intensive Care Units, Pediatric; Male; Pulmonary Disease, Chronic Obstructive; Renin; Renin-Angiotensin System; Retrospective Studies; Stroke Volume; Treatment Outcome | 2019 |
Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.
Topics: Airway Remodeling; Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Disease Models, Animal; Female; Imidazoles; Inflammation Mediators; Lung; Macrophages, Alveolar; Mice, Inbred BALB C; Neutrophils; Oxidative Stress; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Smoke; Sulfonamides; Thiophenes; Tobacco Products | 2020 |